{"doc_id": "33764850", "type of study": "Therapy", "title": "", "abstract": "Probiotics reduce self-reported symptoms of upper respiratory tract infection in overweight and obese adults: should we be considering probiotics during viral pandemics?\nGut microbiome manipulation to alter the gut-lung axis may potentially protect humans against respiratory infections, and clinical trials of probiotics show promise in this regard in healthy adults and children.\nHowever, comparable studies are lacking in overweight/obese people, who have increased risks in particular of viral upper respiratory tract infections (URTI).\nThis Addendum further analyses our recent placebo-controlled trial of probiotics in overweight/obese people (focused initially on weight loss) to investigate the impact of probiotics upon the occurrence of URTI symptoms.\nAs well as undergoing loss of weight and improvement in certain metabolic parameters, study participants taking probiotics experienced a 27% reduction in URTI symptoms versus control, with those \u226545\u00a0years or BMI \u226530\u2009kg/m2 experiencing greater reductions.\nThis symptom reduction is apparent within 2 weeks of probiotic use.\nGut microbiome diversity remained stable throughout the study in probiotic-treated participants.\nOur data provide support for further trials to assess the potential role of probiotics in preventing viral URTI (and possibly also COVID-19), particularly in overweight/obese people.\n", "Evidence Map": {"Enrollment": [{"term": "overweight", "negation": "affirmed", "UMLS": {}, "start": 81, "end": 91}, {"term": "obese", "negation": "affirmed", "UMLS": {}, "start": 96, "end": 101}, {"term": "viral", "negation": "affirmed", "UMLS": {}, "start": 154, "end": 159}, {"term": "healthy", "negation": "affirmed", "UMLS": {}, "start": 184, "end": 191}, {"term": "obese", "negation": "affirmed", "UMLS": {}, "start": 97, "end": 102}, {"term": "\u226545 years", "negation": "affirmed", "UMLS": {}, "start": 198, "end": 207}, {"term": "BMI \u226530", "negation": "affirmed", "UMLS": {}, "start": 211, "end": 218}, {"term": "m2", "negation": "affirmed", "UMLS": {}, "start": 224, "end": 226}], "Comparison Results": [], "Study Arm 1 Results": [], "Study Arm 2 Results": [], "Hypothesis": []}, "Sentence-level breakdown": [{"Section": "TITLE", "Text": "Probiotics reduce self-reported symptoms of upper respiratory tract infection in overweight and obese adults : should we be considering probiotics during viral pandemics ?", "Evidence Elements": {"Participant": [{"term": "overweight", "negation": "affirmed", "UMLS": {}, "start": 81, "end": 91}, {"term": "obese", "negation": "affirmed", "UMLS": {}, "start": 96, "end": 101}, {"term": "viral", "negation": "affirmed", "UMLS": {}, "start": 154, "end": 159}], "Intervention": [{"term": "Probiotics", "negation": "affirmed", "UMLS": {}, "start": 0, "end": 10, "has_relation": "N/A"}, {"term": "probiotics", "negation": "affirmed", "UMLS": {}, "start": 136, "end": 146, "has_relation": "N/A"}], "Outcome": [{"term": "self-reported symptoms of upper respiratory tract infection", "negation": "affirmed", "UMLS": {}, "start": 18, "end": 77}], "Observation": [{"term": "reduce", "negation": "affirmed", "UMLS": {}, "start": 11, "end": 17}], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "Gut microbiome manipulation to alter the gut-lung axis may potentially protect humans against respiratory infections , and clinical trials of probiotics show promise in this regard in healthy adults and children .", "Evidence Elements": {"Participant": [{"term": "healthy", "negation": "affirmed", "UMLS": {}, "start": 184, "end": 191}], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "However , comparable studies are lacking in overweight / obese people , who have increased risks in particular of viral upper respiratory tract infections ( URTI ) .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "This Addendum further analyses our recent placebo-controlled trial of probiotics in overweight / obese people ( focused initially on weight loss ) to investigate the impact of probiotics upon the occurrence of URTI symptoms .", "Evidence Elements": {"Participant": [{"term": "obese", "negation": "affirmed", "UMLS": {}, "start": 97, "end": 102}], "Intervention": [{"term": "probiotics", "negation": "affirmed", "UMLS": {}, "start": 70, "end": 80, "has_relation": "N/A"}, {"term": "probiotics", "negation": "affirmed", "UMLS": {}, "start": 70, "end": 80, "has_relation": "N/A"}], "Outcome": [{"term": "occurrence of", "negation": "affirmed", "UMLS": {}, "start": 196, "end": 209}], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "As well as undergoing loss of weight and improvement in certain metabolic parameters , study participants taking probiotics experienced a 27 % reduction in URTI symptoms versus control , with those \u226545 years or BMI \u226530 kg / m2 experiencing greater reductions .", "Evidence Elements": {"Participant": [{"term": "\u226545 years", "negation": "affirmed", "UMLS": {}, "start": 198, "end": 207}, {"term": "BMI \u226530", "negation": "affirmed", "UMLS": {}, "start": 211, "end": 218}, {"term": "m2", "negation": "affirmed", "UMLS": {}, "start": 224, "end": 226}], "Intervention": [{"term": "probiotics", "negation": "affirmed", "UMLS": {}, "start": 113, "end": 123, "has_relation": "N/A"}, {"term": "control", "negation": "affirmed", "UMLS": {}, "start": 177, "end": 184, "has_relation": "N/A"}], "Outcome": [{"term": "loss of weight", "negation": "affirmed", "UMLS": {}, "start": 22, "end": 36}, {"term": "metabolic parameters", "negation": "affirmed", "UMLS": {}, "start": 64, "end": 84}, {"term": "URTI symptoms", "negation": "affirmed", "UMLS": {}, "start": 156, "end": 169}], "Observation": [{"term": "improvement", "negation": "affirmed", "UMLS": {}, "start": 41, "end": 52}, {"term": "27 % reduction", "negation": "affirmed", "UMLS": {}, "start": 138, "end": 152}], "Count": []}, "Evidence Propositions": [{"Intervention": {"term": "probiotics", "has_relation": "N/A"}, "Observation": "27 % reduction", "Outcome": "URTI symptoms", "Count": ""}, {"Intervention": {"term": "control", "has_relation": "N/A"}, "Observation": "27 % reduction", "Outcome": "URTI symptoms", "Count": ""}]}, {"Section": "UNKNOWN", "Text": "This symptom reduction is apparent within 2 weeks of probiotic use .", "Evidence Elements": {"Participant": [], "Intervention": [{"term": "probiotic use", "negation": "affirmed", "UMLS": {}, "start": 53, "end": 66, "has_relation": "N/A"}], "Outcome": [{"term": "symptom reduction", "negation": "affirmed", "UMLS": {}, "start": 5, "end": 22}], "Observation": [{"term": "apparent", "negation": "affirmed", "UMLS": {}, "start": 26, "end": 34}], "Count": []}, "Evidence Propositions": [{"Intervention": {"term": "probiotic use", "has_relation": "N/A"}, "Observation": "apparent", "Outcome": "symptom reduction", "Count": ""}]}, {"Section": "UNKNOWN", "Text": "Gut microbiome diversity remained stable throughout the study in probiotic-treated participants .", "Evidence Elements": {"Participant": [], "Intervention": [{"term": "probiotic-treated", "negation": "affirmed", "UMLS": {}, "start": 65, "end": 82, "has_relation": "N/A"}], "Outcome": [{"term": "Gut microbiome diversity", "negation": "affirmed", "UMLS": {}, "start": 0, "end": 24}], "Observation": [{"term": "remained stable", "negation": "affirmed", "UMLS": {}, "start": 25, "end": 40}], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "Our data provide support for further trials to assess the potential role of probiotics in preventing viral URTI ( and possibly also COVID-19 ) , particularly in overweight / obese people .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [{"term": "viral", "negation": "affirmed", "UMLS": {}, "start": 101, "end": 106}], "Observation": [], "Count": []}, "Evidence Propositions": []}]}